COVID-19 vaccine trials should seek worthwhile efficacy
- 27 August 2020
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 396 (10253), 741-743
- https://doi.org/10.1016/s0140-6736(20)31821-3
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Rapid COVID-19 vaccine developmentScience, 2020
- COVID-19 vaccine design: the Janus face of immune enhancementNature Reviews Immunology, 2020
- Creating a Framework for Conducting Randomized Clinical Trials during Disease OutbreaksThe New England Journal of Medicine, 2020
- Vaccine confidence in the time of COVID-19European Journal of Epidemiology, 2020
- Current issues in non‐inferiority trialsStatistics in Medicine, 2007